Locations:
Search IconSearch
August 14, 2024/Innovations

Crain’s Cleveland Business: Centerline Biomedical Looks to Change ‘Current Gold Standard’ for Endovascular Intervention

Cleveland Clinic Innovations portfolio company Centerline Biomedical’s Intra-Operative Positioning System (IOPS) aims to help clinicians visualize endovascular tools in real-time and reduce their dependence on fluoroscopy systems.

Doctor with endovascular model

The use of fluoroscopy in orthopedic procedures presents a potential health risk to surgeons due to radiation exposure, even with the use of protective equipment. Centerline Biomedical, a Cleveland Clinic Innovations med-tech portfolio company, aims to address this issue with its Intra-Operative Positioning System (IOPS). Recently receiving FDA clearance for its IOPS Viewpoint Catheter, the company's technology aims to reduce reliance on fluoroscopy systems and protect clinicians from radiation exposure.

The IOPS system, based on electromagnetic tracking, creates real-time visualization of endovascular tools, offering a safer alternative to fluoroscopy. Developed as a collaboration between former Cleveland Clinic researcher Vikash Goel and the late Dr. Roy Greenberg, the technology aims to improve visualization during endovascular interventions and reduce the health risks associated with prolonged radiation exposure for surgeons.

Centerline Biomedical's IOPS system, designed to provide real-time navigation feedback, consists of a portable cart, electromagnetic field generator, sensor interface unit, and specially designed catheters and guidewires with integrated sensors. The company has been continually improving its system based on feedback from early adopters and is set to release new hardware and software updates, with plans for further upgrades in the coming years. In addition to reducing radiation exposure, the IOPS technology has the potential to enhance efficiency in the operating room, allowing doctors to work more effectively by providing clearer visualization. With the appointment of a new Chief Financial Officer and a successful $33 million Series B equity financing round in 2022, Centerline Biomedical is poised to further advance its mission of providing a safer and more efficient alternative to fluoroscopy for orthopedic procedures.

Read the full article via Crain’s Cleveland Business.

Subscribe to Cleveland Clinic Innovations' Newsletter

Follow Cleveland Clinic Innovations on LinkedIn

Latest from the Newsroom

Dr. Brenessa Lindeman

Brenessa Lindeman, M.D., Appointed Executive Dean of Cleveland Clinic Lerner College of Medicine

Logos for Cleveland Clinic and West Side Market

Cleveland Clinic Pledges $1 Million to Support Teaching Kitchen at West Side Market

Exterior photo of Cleveland Clinic's Main Campus

Cleveland Clinic One of the Nation’s Best Hospitals

Photo of a drone that delivers medications.

Cleveland Clinic Launches Drone Delivery Program for Prescription Medications

Eye mask on a pillow

AI Identifies Previously Unrecognized Health Insights in Routine Sleep Studies

Artist's rendering of expansion plans at Cleveland Clinic's Richard E. Jacobs Campus in Avon

Cleveland Clinic Breaks Ground on Avon Campus Expansion

Logos for Cleveland Clinic and Siemens Healthineers

Siemens Healthineers and Cleveland Clinic Launch 10-year Strategic Alliance to Enhance Care Through Clinical Innovation and Advanced Imaging

Logos for Cleveland Clinic and WNBA Cleveland

Cleveland WNBA Names Cleveland Clinic as Third Founding Partner and Official Hospital and Sports Medicine Provider